What MS Downturn? Bruker is Latest to Launch New Instrument with ultrafleXtreme MALDI-TOF/TOF
April 30, 2009
What MS Downturn? Bruker is Latest to Launch New Instrument with ultrafleXtreme MALDI-TOF/TOF
The anticipated weak mass-spec market has not stopped vendors from launching new instruments, which may pay off later in the year when spending from the economic stimulus package could hit instrument manufacturers.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Compensation for Most Mass-Spec CEOs Drops Sharply in 2009
April 23, 2010 / ProteoMonitor - Thermo Fisher 'Ruthlessly' Focused on Winning in Mass-Spec Space, CEO Tells Investors
January 15, 2010 / ProteoMonitor - Mass Spec Officials Talk M&A Progress, Strategies at UBS Conference
September 24, 2009 / ProteoMonitor - Mass Spec Firms Among Best Performers in GWDN Index
July 9, 2009 / ProteoMonitor - ABI/MDS Launch MALDI MS to Re-energize Venture
April 29, 2009 / Genome Technology